Evolus’s Botox Rival Loses First Round Over AbbVie’s Allergan

AbbVie Inc.’s Allergan and its Korean partner Medytox Inc. won the first round of a U.S. trade dispute in which they are trying to block imports of Evolus Inc.’s Jeuveau, a rival to the Botox wrinkle treatment.

Evolus’s partner, Daewoong Pharmaceuticals Co., said that U.S. International Trade Commission Judge David Shaw sided against them and found that Medytox business secrets had been stolen. The judge’s findings are subject to review by the commission, which has the power to block imports of products that violate U.S. intellectual property rights and is scheduled to complete the investigation in November.

Daewoong ...